Parkinson's in a dish: Researchers reproduce brain oscillations

May 2, 2017, University at Buffalo
"With this new finding, we can now generate in a dish the neuronal misfiring that is similar to what occurs in the brain of a Parkinson's patient," said Feng. Credit: Douglas Levere, University at Buffalo

Abnormal oscillations in neurons that control movement, which likely cause the tremors that characterize Parkinson's disease, have long been reported in patients with the disease. Now, University at Buffalo researchers working with stem cells report that they have reproduced these oscillations in a petri dish, paving the way for much faster ways to screen for new treatments or even a cure for Parkinson's disease.

The paper is published online today (May 2) in Cell Reports.

"With this new finding, we can now generate in a dish the neuronal misfiring that is similar to what occurs in the brain of a Parkinson's patient," said Jian Feng, PhD, senior author on the paper and professor in the Department of Physiology and Biophysics in the Jacobs School of Medicine and Biomedical Sciences at UB. "A variety of studies and drug discovery efforts can be implemented on these human neurons to speed up the discovery of a cure for Parkinson's disease."

The work provides a useful platform for better understanding the molecular mechanisms at work in the disease, he added.

Rhythmic bursts

Abnormal brain oscillations first came to light decades ago when some Parkinson's patients began undergoing as treatment once their medications ceased to be effective. Neurosurgeons doing the procedure noticed rhythmic bursts of activity or oscillations among neurons in patients when they used electrodes to override brain activity in order to stimulate the brain.

"Our bodies move because there is coordination between the contracting and relaxing of our muscles," explained Feng. "It's all exquisitely timed within the brain structure called basal ganglia."

The rhythmic bursts of activity or oscillations that neurosurgeons saw in the brains of Parkinson's patients signaled that something in that system had broken down but exactly how wasn't clear.

Neuronal nonsense

Feng and his colleagues generated induced pluripotent (iPSCs) from the skin cells of patients with mutations in the parkin gene. Years earlier, Feng's team had used the same technology to discover that these mutations cause Parkinson's disease by disrupting the actions of dopamine, which is necessary for normal physical movement. When there isn't enough dopamine, an imbalance in neurotransmission occurs, ultimately resulting in Parkinson's disease.

"What we found in our new research is pretty dramatic," he said. "When we recorded electrical activity in the neurons with parkin mutations, you could clearly see the oscillations."

The mutations induce a change in how neurons communicate, Feng said.

"Normally, communication between these neurons is not repetitive," he said, "but in this case, we suspect that the oscillation reduces the information content being transmitted. It's almost like stuttering, as though now the neuron can't understand the instructions for normal movement. All the neurons 'hear' is nonsense."

To make sure that the oscillations were caused by parkin mutations, the researchers then used a virus to rescue the mutations. With normal parkin back in the neuron, the oscillations disappeared.

Potential drugs

"This research gives us a very nice way to screen for drugs because the phenotype is very much like what is going on in the ," Feng said. "Whatever blocks the in the dish could be a candidate." This idea led to discussions with Q-State Biosciences, a startup developed by Harvard University professors Adam E. Cohen, PhD, and Kevin Eggan, PhD, that focuses on stem cell and optogenetic technologies.

Feng noted that the UB research was extremely tedious. The had to be cultured for more than 100 days and the medium needed to be changed every two days. Q-State Biosciences is interested in developing a high-throughput technique, which would be highly valuable to pharmaceutical companies that want to quickly screen potential drug candidates for Parkinson's disease.

Explore further: Parkinson's disease: Study of live human neurons reveals the disease's genetic origins

Related Stories

Parkinson's disease: Study of live human neurons reveals the disease's genetic origins

February 7, 2012
Parkinson's disease researchers at the University at Buffalo have discovered how mutations in the parkin gene cause the disease, which afflicts at least 500,000 Americans and for which there is no cure.

Team identifies mechanism of dopaminergic neuronal death inhibition using stress hormone cortisol

April 26, 2017
DGIST's research team has found a candidate substance that can prevent and cure Parkinson's disease. By using this substance, the team also has identified the mechanism of dopaminergic neuronal death inhibition.

Conversion of brain cells offers hope for Parkinson's patients

April 11, 2017
Researchers at Karolinska Institutet have made significant progress in the search for new treatments for Parkinson's disease. By manipulating the gene expression of non-neuronal cells in the brain, they were able to produce ...

Scientific discovery may change treatment of Parkinson's disease

March 22, 2017
When monitoring Parkinson's disease, SPECT imaging of the brain is used for acquiring information on the dopamine activity. A new study conducted in Turku, Finland, shows that the dopamine activity observed in SPECT imaging ...

Discovery of genetic 'switch' could help to prevent symptoms of Parkinson's disease

February 17, 2017
A genetic 'switch' has been discovered by MRC researchers at the University of Leicester which could help to prevent or delay the symptoms of Parkinson's disease.

Discovery puts designer dopamine neurons within reach

December 7, 2015
For decades, the elusive holy grail in Parkinson's disease research has been finding a way to repair faulty dopamine neurons and put them back into patients, where they will start producing dopamine again. Researchers have ...

Recommended for you

Aggressive immune cells aggravate Parkinson's disease

July 20, 2018
Parkinson's disease, formerly referred to as "shaking palsy," is one of the most common disorders affecting movement and the nervous system. Medical researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) ...

Researchers trace Parkinson's damage in the heart

July 13, 2018
A new way to examine stress and inflammation in the heart will help Parkinson's researchers test new therapies and explore an unappreciated way the disease puts people at risk of falls and hospitalization.

Study raises doubts on a previous theory of Parkinson's disease

July 6, 2018
Parkinson's disease was first described by a British doctor more than 200 years ago. The exact causes of this neurodegenerative disease are still unknown. In a study recently published in eLife, a team of researchers led ...

Drug protects neurons in Parkinson's disease

June 27, 2018
Systemic treatment of animal models with israpidine, a calcium channel inhibitor, reduced mitochondrial stress that might cause Parkinson's disease, according to a Northwestern Medicine study published in the Journal of Clinical ...

Half of those on Parkinson's drugs may develop impulse control problems

June 20, 2018
Over time, half of the people taking certain drugs for Parkinson's disease may develop impulse control disorders such as compulsive gambling, shopping or eating, according to a study published in the June 20, 2018, online ...

New evidence sheds light on how Parkinson's disease may happen

June 14, 2018
Researchers at Baylor College of Medicine and Texas Children's Hospital have identified unexpected new key players in the development of an early onset form of Parkinson's disease called Parkinsonism. These key players are ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.